These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 6265016

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The effects of dimercaptosuccinic acid and other chelating agents on the retention of platinum in the rat kidney after treatment with cisplatin.
    Planas-Bohne F, Shand E, Taylor DM.
    Cancer Chemother Pharmacol; 1982; 9(2):120-1. PubMed ID: 6293731
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Determination and metabolism of dithiol chelating agents: the zinc chelate of the dimethyl ester of meso-2,3-dimercaptosuccinic acid increase biliary excretion of cadmium and platinum.
    Aposhian HV, Levine DJ, Rivera M, Fernando Q.
    Chem Res Toxicol; 1993; 6(2):208-14. PubMed ID: 8386560
    [Abstract] [Full Text] [Related]

  • 5. Cisplatin-induced loss of kidney copper and nephrotoxicity is ameliorated by single dose diethyldithiocarbamate, but not mesna.
    DeWoskin RS, Riviere JE.
    Toxicol Appl Pharmacol; 1992 Feb; 112(2):182-9. PubMed ID: 1311464
    [Abstract] [Full Text] [Related]

  • 6. The effects of 2,3-dimercapto-1-propanesulfonic acid (DMPS) and meso-2,3-dimercaptosuccinic acid (DMSA) on the nephrotoxicity in the mouse during repeated cisplatin (CDDP) treatments.
    Yajima Y, Kawaguchi M, Yoshikawa M, Okubo M, Tsukagoshi E, Sato K, Katakura A.
    J Pharmacol Sci; 2017 Jun; 134(2):108-115. PubMed ID: 28648300
    [Abstract] [Full Text] [Related]

  • 7. Control of nephrotoxicity in the rat during repeated cis-platinum treatments.
    Jones MM, Basinger MA.
    J Appl Toxicol; 1989 Aug; 9(4):229-33. PubMed ID: 2778256
    [Abstract] [Full Text] [Related]

  • 8. Protection against cis-diamminedichloroplatinum-induced nephrotoxicity by 2,3-dimercaptosuccinic acid in rats.
    Mishima K, Hidaka S, Takamura N, Shinozawa S.
    Ren Fail; 1999 Nov; 21(6):593-602. PubMed ID: 10586422
    [Abstract] [Full Text] [Related]

  • 9. Magnesium co-administration decreases cisplatin-induced nephrotoxicity in the multiple cisplatin administration.
    Saito Y, Okamoto K, Kobayashi M, Narumi K, Furugen A, Yamada T, Iseki K.
    Life Sci; 2017 Nov 15; 189():18-22. PubMed ID: 28864226
    [Abstract] [Full Text] [Related]

  • 10. L-methionine antagonism of cis-platinum nephrotoxicity.
    Basinger MA, Jones MM, Holscher MA.
    Toxicol Appl Pharmacol; 1990 Mar 15; 103(1):1-15. PubMed ID: 2315922
    [Abstract] [Full Text] [Related]

  • 11. Protection effects of Taurine supplementation against cisplatin-induced nephrotoxicity in rats.
    Saad SY, Al-Rikabi AC.
    Chemotherapy; 2002 Mar 15; 48(1):42-8. PubMed ID: 11901256
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of nitric oxide synthase aggravates cisplatin-induced nephrotoxicity: effect of 2-amino-4-methylpyridine.
    Saad SY, Najjar TA, Daba MH, Al-Rikabi AC.
    Chemotherapy; 2002 Mar 15; 48(6):309-15. PubMed ID: 12673106
    [Abstract] [Full Text] [Related]

  • 13. Comparison of the effectiveness of 2,3-dimercaptopropanol (BAL) and meso-2,3-dimercaptosuccinic acid (DMSA) as protective agents against mercuric chloride-induced nephrotoxicity in rats.
    de la Torre A, Bellés M, Llobet JM, Mayayo E, Domingo JL.
    Biol Trace Elem Res; 1998 Jul 15; 63(1):1-10. PubMed ID: 9764565
    [Abstract] [Full Text] [Related]

  • 14. Protective effects of verapamil on cis-platinum and carboplatinum nephrotoxicity in dehydrated and normohydrated rats.
    Haragsim L, Zima T.
    Biochem Int; 1992 Oct 15; 28(2):273-6. PubMed ID: 1360799
    [Abstract] [Full Text] [Related]

  • 15. Dithiocarbamate-induced biliary platinum excretion and the control of cis-platinum nephrotoxicity.
    Basinger MA, Jones MM, Gilbreath SG, Walker EM, Fody EP, Mayhue MA.
    Toxicol Appl Pharmacol; 1989 Feb 15; 97(2):279-88. PubMed ID: 2538006
    [Abstract] [Full Text] [Related]

  • 16. Protective effect of elastase on cis-platinum-induced renal toxicity.
    Suzuki M, Sekiguchi I, Tamada T, Tsuru S.
    Oncology; 1991 Feb 15; 48(6):474-9. PubMed ID: 1749585
    [Abstract] [Full Text] [Related]

  • 17. Amelioration of cisplatin-induced nephrotoxicity by the diuretic acetazolamide in F344 rats.
    Osman NM, Copley MP, Litterst CL.
    Cancer Treat Rep; 1984 Feb 15; 68(7-8):999-1004. PubMed ID: 6540145
    [Abstract] [Full Text] [Related]

  • 18. [Clinical investigation of cis-platinum nephrotoxicity in 244 cases of primary lung cancer].
    Soejima A, Inoue T, Suzuki M, Waku M, Nakabayashi K, Kitamoto K, Nagasawa T.
    Nihon Jinzo Gakkai Shi; 1992 Jul 15; 34(7):801-6. PubMed ID: 1479719
    [Abstract] [Full Text] [Related]

  • 19. Effects of mycophenolate mofetil on cisplatin-induced renal dysfunction in rats.
    Saad SY, Arafah MM, Najjar TA.
    Cancer Chemother Pharmacol; 2007 Mar 15; 59(4):455-60. PubMed ID: 16855841
    [Abstract] [Full Text] [Related]

  • 20. Nephrotoxicity of a novel antineoplastic platinum complex, nedaplatin: a comparative study with cisplatin in rats.
    Uehara T, Watanabe H, Itoh F, Inoue S, Koshida H, Nakamura M, Yamate J, Maruyama T.
    Arch Toxicol; 2005 Aug 15; 79(8):451-60. PubMed ID: 15856183
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.